Close Menu

NEW YORK – Ideaya Biosciences on Thursday announced that it had partnered with the Sellers Laboratory at the Broad Institute of MIT and Harvard to generate target and biomarker discoveries for the treatment of patients with ovarian and breast cancers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
15
Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.